US2022288313A1PendingUtilityA1

Regulation of insulin on board

Assignee: MEDTRONIC MINIMED INCPriority: Apr 24, 2014Filed: May 26, 2022Published: Sep 15, 2022
Est. expiryApr 24, 2034(~7.7 yrs left)· nominal 20-yr term from priority
Inventors:Cesar C. Palerm
A61M 5/14244A61M 5/1452A61M 5/1684A61M 5/1723A61M 2005/14208A61M 2005/1726
71
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed herein are techniques related to regulation of insulin on board. In some examples, the techniques may involve obtaining a glucose measurement value generated from a sensing arrangement. The techniques may also involve determining that the glucose measurement value is a valid glucose measurement value. Furthermore, the techniques may involve maintaining a threshold amount of insulin on board (IOB) based on regulating insulin delivery. Maintaining the threshold amount of IOB may be performed responsive to the valid glucose measurement value being less than a threshold glucose value.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A system comprising:
 one or more processors; and   one or more processor-readable media storing instructions which, when executed by the one or more processors, cause performance of:
 obtaining a glucose measurement value generated from a sensing arrangement; 
 determining that the glucose measurement value is a valid glucose measurement value; and 
 responsive to the valid glucose measurement value being less than a threshold glucose value, maintaining a threshold amount of insulin on board (IOB) based on regulating insulin delivery. 
   
     
     
         2 . The system of  claim 1 , wherein regulating insulin delivery comprises causing suspension of insulin delivery. 
     
     
         3 . The system of  claim 2 , wherein causing suspension of insulin delivery comprises:
 determining that a current amount of IOB is greater than the threshold amount of IOB; and   responsive to determining that the current amount of IOB is greater than the threshold amount of IOB, causing suspension of insulin delivery to decrease the current amount to the threshold amount.   
     
     
         4 . The system of  claim 1 , wherein regulating insulin delivery further comprises:
 determining that a current amount of IOB is less than the threshold amount of IOB; and   responsive to determining that the current amount of IOB is less than the threshold amount of IOB, causing delivery of insulin to increase the current amount to the threshold amount.   
     
     
         5 . The system of  claim 1 , wherein regulating insulin delivery comprises:
 regulating an insulin delivery rate to a minimum rate for maintaining the threshold amount of IOB.   
     
     
         6 . The system of  claim 5 , wherein the insulin delivery rate is a basal infusion rate. 
     
     
         7 . The system of  claim 1 , wherein the threshold glucose value corresponds to a threshold value for insulin delivery suspension. 
     
     
         8 . A processor-implemented method comprising:
 obtaining a glucose measurement value generated from a sensing arrangement;   determining that the glucose measurement value is a valid glucose measurement value; and   responsive to the valid glucose measurement value being less than a threshold glucose value, maintaining a threshold amount of insulin on board (IOB) based on regulating insulin delivery.   
     
     
         9 . The method of  claim 8 , wherein regulating insulin delivery comprises causing suspension of insulin delivery. 
     
     
         10 . The method of  claim 9 , wherein causing suspension of insulin delivery comprises:
 determining that a current amount of IOB is greater than the threshold amount of IOB; and   responsive to determining that the current amount of IOB is greater than the threshold amount of IOB, causing suspension of insulin delivery to decrease the current amount to the threshold amount.   
     
     
         11 . The method of  claim 9 , wherein regulating insulin delivery further comprises:
 determining that a current amount of IOB is less than the threshold amount of IOB; and   responsive to determining that the current amount of IOB is less than the threshold amount of IOB, causing delivery of insulin to increase the current amount to the threshold amount.   
     
     
         12 . The method of  claim 8 , wherein regulating insulin delivery comprises:
 regulating an insulin delivery rate to a minimum rate for maintaining the threshold amount of IOB.   
     
     
         13 . The method of  claim 12 , wherein the insulin delivery rate is a basal infusion rate. 
     
     
         14 . The method of  claim 8 , wherein the threshold glucose value corresponds to a threshold value for insulin delivery suspension. 
     
     
         15 . One or more non-transitory processor-readable media storing instructions which, when executed by one or more processors, cause performance of:
 obtaining a glucose measurement value generated from a sensing arrangement;   determining that the glucose measurement value is a valid glucose measurement value; and   responsive to the valid glucose measurement value being less than a threshold glucose value, maintaining a threshold amount of insulin on board (IOB) based on regulating insulin delivery.   
     
     
         16 . The one or more non-transitory processor-readable media of  claim 15 , wherein regulating insulin delivery comprises causing suspension of insulin delivery. 
     
     
         17 . The one or more non-transitory processor-readable media of  claim 16 , wherein causing suspension of insulin delivery comprises:
 determining that a current amount of IOB is greater than the threshold amount of IOB; and   responsive to determining that the current amount of IOB is greater than the threshold amount of IOB, causing suspension of insulin delivery to decrease the current amount to the threshold amount.   
     
     
         18 . The one or more non-transitory processor-readable media of  claim 16 , wherein regulating insulin delivery further comprises:
 determining that a current amount of IOB is less than the threshold amount of IOB; and   responsive to determining that the current amount of IOB is less than the threshold amount of IOB, causing delivery of insulin to increase the current amount to the threshold amount.   
     
     
         19 . The one or more non-transitory processor-readable media of  claim 15 , wherein regulating insulin delivery comprises:
 regulating an insulin delivery rate to a minimum rate for maintaining the threshold amount of IOB.   
     
     
         20 . The one or more non-transitory processor-readable media of  claim 19 , wherein the insulin delivery rate is a basal infusion rate.

Join the waitlist — get patent alerts

Track US2022288313A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.